COMMUNIQUÉS West-GlobeNewswire

Adverum Biotechnologies Announces Closing of $69 Million Public Offering
12/02/2018
MENLO PARK, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]
Onconova Therapeutics Announces Closing of $10 Million Underwritten Public Offering and Exercise in Full of the Underwriter’s Option to Purchase Additional Securities
12/02/2018
NEWTOWN, Pa., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ) (“Onconova” or “we”), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug [...]
Franciscan Alliance, Circulation Unveil Non-Emergency Transportation Partnership
12/02/2018
MISHAWAKA, Indiana, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Hospital patients with ongoing medical conditions often are unable to receive the care they need because they don’t have transportation to see their doctors or make [...]
CROSSJECT :Information relative au nombre total de droits de vote et d'actions composant le capital social
12/02/2018
Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 12 février 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Athersys to Host Year-End 2017 Financial Results Call
12/02/2018
CLEVELAND, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX ) will release its year-end 2017 financial results at approximately 4:00 PM Eastern Time on Tuesday, March 13, 2018, and will host a conference [...]
CROSSJECT :ATTRIBUTION GRATUITE DE BONS DE SOUSCRIPTION D'ACTIONS (BSA) ET RENFORCEMENT DE SES FONDS PROPRES PAR UNE ÉMISSION OBLIGATAIRE CONVERTIBLE D'UN MONTANT DE 5,250 M€
12/02/2018
Communiqué de Presse CROSSJECT ANNONCE L'ATTRIBUTION GRATUITE DE BONS DE SOUSCRIPTION D'ACTIONS (BSA) AU BENEFICE DES ACTIONNAIRES DE LA SOCIETE ET LE RENFORCEMENT DE SES FONDS PROPRES PAR UNE ÉMISSION OBLIGATAIRE [...]
Bionano Genomics Announces Global Launch of its New Direct Labeling Chemistry for Genome Mapping and Structural Variation Analysis
12/02/2018
Direct Labeling chemistry provides chromosome arm length maps and improves SV detection resolution down to 500 bp for as little as $500 per genome To be showcased at the AGBT General Meeting this week SAN DIEGO, Feb. 12 [...]
Sanofi: Disclosure of trading in own shares
12/02/2018
Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/c0c53934-7270-4d20-990d-48714cfcded3
Sanofi : Déclaration des transactions sur actions propres
12/02/2018
Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/107c7dc4-5d1a-4365-9889-5947e1b6cce7
Ossur Hf : Transactions in relation to share buyback program
12/02/2018
Announcement from Össur hf. No. 9/2018 Reykjavík, 12 February 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
CyberFuels Inc. gains approval for EcoFlex 96 to be sold in Texas and plans to acquire Texas Bulk Fuel Distributor
12/02/2018
PALM BEACH, Fla., Feb. 12, 2018 (GLOBE NEWSWIRE) -- EncounterCare Solutions (OTC:ESCL) is pleased to announce that its wholly owned subsidiary, CyberFuels Inc. will begin selling its EcoFlex 96 fuel in Texas. Under the [...]
Precision Imaging Centers Implements eRAD RIS, Portals, and RADAR
12/02/2018
GREENVILLE, S.C., Feb. 12, 2018 (GLOBE NEWSWIRE) -- eRAD, a subsidiary of RadNet, Inc., a leading provider of standards-based, web-centric radiology image and data management solutions, announced today that Precision [...]
PRA Health Sciences Partners with IMPACT2030
12/02/2018
RALEIGH, N.C., Feb. 12, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH ) is pleased to announce that it has joined IMPACT2030 as a collaborating partner. IMPACT2030 is a coalition of businesses working [...]
Remedy Pharmaceuticals Co-founder and CEO Brings Clinical Trial and Company-Building Experience to ReNetX Bio Advisory Board
12/02/2018
NEW HAVEN, Conn., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Sven Jacobson will be the first to admit that developing a new therapeutic for spinal cord injury is a challenging road. But the latest member of the ReNetX Advisory [...]
Anti-Aging Patent Application Filed; Exclusive Commercial Rights to Premier Biomedical, Inc.
12/02/2018
JACKSON CENTER, Pa., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) announced today the filing of a patent application, “Method For Slowing The Aging Process”, by Mitchel S. Felder, MD, the [...]
Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device
12/02/2018
LOS ANGELES, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive wearable Electroceutical™ devices, today announced [...]
Merit Medical Systems to Announce Fourth Quarter and Year End Results on February 28, 2018
12/02/2018
SOUTH JORDAN, Utah, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI ), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and [...]
BioCorRx Announces Results of Pre-IND meeting with FDA for Sustained Release Naltrexone Implant, BICX102
12/02/2018
505(b)(2) application plan acceptable per FDA Application will seek dual indications for opioid and alcohol use disorders ANAHEIM, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a [...]
Advantis Corp. Unexpectedly Set To Triple California Amster-Can Revenue by End of 2nd Quarter
12/02/2018
NEWPORT BEACH, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) is currently working with new and existing partners to more than triple the total California Amster-Can canning production. Two [...]

Pages